Capital Rx
United States
- New York, New York
- 14/08/2023
- Unknown
- Undisclosed Amount
Capital Rx is a healthcare technology company changing the way prescription drugs are priced, and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single Ledger Model™, the industry’s first ethical framework for drug pricing. The company’s cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem in one system, empowering Capital Rx to deliver exceptional service to its commercial, Medicare, and Medicaid clients and members 24/7, 365 days a year. Together with its clients, Capital Rx is reimagining the administration of pharmacy benefits and rebuilding trust in healthcare.
- Industry Hospital & Health Care
- Website https://www.cap-rx.com/
- LinkedIn https://www.linkedin.com/company/cap-rx/about/
Related People
A. J. LoiaconoFounder
United States -
New York, New York
On a mission to develop the technology infrastructure our country requires, for the healthcare system patients deserve.
Iridius | $8,600,000 | (Apr 28, 2026)
Audion | $15,000,000 | (Apr 28, 2026)
Decade Energy | $25,763,540 | (Apr 28, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Fathom Therapeutics | $47,000,000 | (Apr 28, 2026)
SquareMind | $18,000,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)
Cnuic Technologies | $3,000,000 | (Apr 28, 2026)
Zócalo Health | $15,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)